Page last updated: 2024-09-03

pyroglutamyl diazomethyl ketone and Pituitary Neoplasms

pyroglutamyl diazomethyl ketone has been researched along with Pituitary Neoplasms in 1 studies

*Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suen, CS; Wilk, S1

Other Studies

1 other study(ies) available for pyroglutamyl diazomethyl ketone and Pituitary Neoplasms

ArticleYear
Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine.
    Endocrinology, 1987, Volume: 121, Issue:2

    Topics: Aminopeptidases; Animals; Cell Line; Cycloheximide; Endopeptidases; Enzyme Induction; Hydrolysis; Kinetics; Pituitary Neoplasms; Prolyl Oligopeptidases; Pyroglutamyl-Peptidase I; Pyrrolidonecarboxylic Acid; Rats; Serine Endopeptidases; Triiodothyronine

1987